Format

Send to

Choose Destination
ACS Omega. 2017 Oct 31;2(10):6916-6925. doi: 10.1021/acsomega.7b01134. Epub 2017 Oct 19.

Dihydrosanguinarine Enhances Glucose Uptake in Mouse 3T3-L1 Cells.

Author information

1
Division of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Main Building of Faculty of Agriculture, Room N252, Kitashirakawa, Sakyo, Kyoto 606-8502, Japan.

Abstract

Recently, more studies have aimed at identifying selective peroxisome proliferator-activated receptor gamma (PPARγ) modulators that transactivate the expression of PPARγ-dependent genes as partial agonists to improve diabetic symptoms with fewer side effects compared to classic PPARγ agonists such as thiazolidinediones. We found that dihydrosanguinarine (DHS) treatment induced preadipocyte differentiation and lipid droplet accumulation in 3T3-L1 cells, but this effect is weaker than that elicited by the full PPARγ agonist troglitazone. Furthermore, this effect was reduced by the addition of a PPARγ antagonist, indicating the involvement of PPARγ signaling. Our results suggest that the stimulatory effects of DHS on adipocyte differentiation and insulin sensitivity are mediated by suppressing adenosine monophosphate-activated protein kinase (AMPK) alpha, upregulating the expression of PPARγ and its target genes (particularly Glut-4 and adiponectin) and reducing PPARγ phosphorylation. DHS significantly enhanced the glucose uptake in 3T3-L1 adipocytes without observable cytotoxicity at the effective concentration (5 μM) applied.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center